Overall, the lower orexin levels in MS will have a number of wider implications in regard to glucose monitoring and regulation, as well as in obesity susceptibility and alterations in reward processing. The gene discussed is HCRT; the disease is obesity due to melanocortin 4 receptor deficiency.